Alga-Based Compound Promises Less Bleeding On The Battlefield

May 17, 1999

Previous efforts to reduce bleeding on the battlefield have been unsuccessful, but a new product derived from microscopic plants that live in the ocean may provide the solution. With ONR support, Marine Polymer Technologies of Danvers, Mass., has identified a compound with the ability to induce blood clot formation. The compound, poly-n-acetyl glucosamine, is effective at stopping blood loss from severely bleeding wounds even though it does not contain any of the proteins that are normally associated with clot formation, such as fibrin or thrombin.

Produced in a paper thin sheet that can be attached to a dressing, the product is prepared from a highly pure natural compound derived from the sterile culture and processing of a marine alga. The product is lightweight, easy to transport, and has a shelf life of up to two years. It is not derived from human or animal sources, thus it presents less of a risk for disease transmission.

An added feature of the bandage is that the material can easily be separated from the clotted surface of a wound 10-90 minutes after application, without causing re-bleeding. This feature is attractive to the Navy & Marine Corps as injured individuals are usually transported away from the battlefield to a trauma hospital for surgery.

The bandage stops bleeding rapidly due to its unique mechanism of action; it seals the wound and the red blood cells form a plug as they come into contact with the bandage material. This stops the bleeding, usually within seconds. The formation of the red blood cell plug in turn leads to a high local concentration of platelets and clotting factors, resulting in the formation of a normal clot in a normal time frame.

This product is a considerable improvement the existing technology for dressings. Currently a gauze type material that has no inherent ability to stop bleeding is held over a wound and pressure is applied to stop the loss of blood. The dressing alone is unreliable for hemorrhage control.

Other products are presently in development by other agencies that also promote hemostasis, but they contain clot inducing proteins that are derived from human blood. With such products there is a risk of disease transmission. The product being developed for the Navy does not have human proteins and therefore, presents less of a risk for disease transmission. Also, the bandage is much cheaper to produce due to its source and ease of manufacture.

In addition to use on the battlefield, commercial application for the technology exists in the pre-hospital care arena, including emergency vehicles at accidents and sports related injuries. Further application of the technology may include the cessation of bleeding associated with cardiac catheterization related to angioplasty and angiography, as well as in kidney dialysis.

Pending full review and approval by the U.S. Food and Drug Administration, the product will be available for general use.
-end-


Office of Naval Research

Related Proteins Articles from Brightsurf:

New understanding of how proteins operate
A ground-breaking discovery by Centenary Institute scientists has provided new understanding as to the nature of proteins and how they exist and operate in the human body.

Finding a handle to bag the right proteins
A method that lights up tags attached to selected proteins can help to purify the proteins from a mixed protein pool.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.

Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.

Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.

Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.

Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.

Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.

Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.

Read More: Proteins News and Proteins Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.